31.03.2010:  Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomized trials occurred by the Hellenic Cooperative Oncology Group

“ Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomized trials occurred by the Hellenic Cooperative Oncology Group”
Anticancer Res. 2008 Sep-Oct; 28(5B):2913-20,
Koutras A, Fountzilas G, Dafni U, Dimopoulos M, Pectasides D, Klouvas G, Papakostas P, Kosmidis P, Samantas E, Gogas H, Briasoulis E, Vourli G, Petsas T, Xiros N, Kalofonos HP; Hellenic Cooperative Oncology Group